COMMUNIQUÉS West-GlobeNewswire

-
Pluristem Therapeutics to Host Key Opinion Leader Call on its Acute Radiation Syndrome and Hematological Deficiencies Programs
21/08/2019 -
YSS Corp. Announces Second Quarter 2019 Results and Operational Update
21/08/2019 -
Tonix Pharmaceuticals and Massachusetts General Hospital Enter into Research Collaboration to Develop Tonix’s Third Generation Anti-CD154 Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Organ Transplant Rejection
21/08/2019 -
RedHill Biopharma Announces Acceptance of Oral Presentations on RHB-105 (H. pylori) and RHB-104 (Crohn’s Disease) Phase 3 Data at ACG 2019 Annual Scientific Meeting
21/08/2019 -
Sharps Compliance Reports Fiscal 2019 Fourth Quarter Results
21/08/2019 -
Teleflex to Present at the Wells Fargo Securities 2019 Healthcare Conference
21/08/2019 -
Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency
21/08/2019 -
Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics
21/08/2019 -
Orphazyme Interim Report First Half 2019 Presentation
21/08/2019 -
Amarin to Participate in a Fireside Chat at Citi’s 14th Annual Biotech Conference
21/08/2019 -
Donnelly Group Launches Wholesale Cannabis Distribution Venture, Goodtrip Supply
21/08/2019 -
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019
21/08/2019 -
AroCell AB (publ) Interim Report January 1st to June 30th 2019
21/08/2019 -
Saniona publishes its interim report for the second quarter 2019
21/08/2019 -
Aeterna Zentaris Announces Director Change
21/08/2019 -
Vigil Health Solutions Completes 2019 AGM
21/08/2019 -
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
20/08/2019 -
Arbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its Board of Directors
20/08/2019 -
MRI Interventions’ Achieves 3,000th ClearPoint® Neuro Navigation Procedure
20/08/2019
Pages